XPH Stock Price Prediction

The radar chart shows that buying State Street SPDR S&P Pharmaceuticals ETF (XPH) stock in November has the highest probability of a positive return (90.91%), while March has the lowest probability (23.08%).

XPH's stock price rose by 4.42% in 2024,increased by 31.36% in 2025, and went up by 0.91%in 2026.

No bullish technical signals identified.

No bearish technical signals identified.

XPH has 0 buy signals and 0 sell signals now. Overall the technical rating for XPH is Neutral. Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of XPH

State Street SPDR S&P Pharmaceuticals ETF's overall moving average trend leans more bullish as of March 04 2026, with 0 negative signals and 4 positive signal.

The price prediction chart for State Street SPDR S&P Pharmaceuticals ETF (XPH) stock, as of Invalid Date, forecasts a %% change over the next month, based on its high correlation with stock patterns. The similarity between their price movements over the analyzed periods is %. The right panel lists other stocks with similar price patterns. This prediction is updated every week.

In , State Street SPDR S&P Pharmaceuticals ETF's value is forecasted to reach an average price of $NaN. The price is predicted to fluctuate between a low of $NaN and a high of $NaN.

In , State Street SPDR S&P Pharmaceuticals ETF's value is forecasted to reach an average price of $NaN. The price is predicted to fluctuate between a low of $NaN and a high of $NaN.